Magevac recombinant live vaccinia virus: Began Phase I/II trial

By WIR Staff | Aug 1, 1994 | 7:00 AM GMT

Therion Biologics Corp., Cambridge, Mass.
Product: Magevac recombinant

Read the full 81 word article

How to gain access

Continue reading with a
two-week free trial.